Mutant p53 proteins can also acquire new oncogenic functions (gain of function (GOF) mutations) promoting cell transformation, tumor progression, metastasis, and chemoresistance [5,6,7,143,144,145,146]. This evidence concerns the gene TP53 and neoplasm.